Comparison of Rocuronium and Org 25969 With Cisatracurium and Neostigmine (19.4.310)(P05931)

NCT00451100 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
84
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Merck Sharp & Dohme LLC